PALB2 and invasive ductal breast carcinoma: The mutation frequency of PALB2 in patients diagnosed with pure or mixed invasive micropapillary carcinoma was 4.26%, which was approximately 6-fold higher than that in patients diagnosed with invasive ductal carcinoma (0.73%).